Radiologic diagnosis of Extranodal Extension (ENE) in patients with HPV-positive oropharyngeal cancer: consensus diagnosis and influence on prognosis

被引：0
|
作者：
Huang, Shao Hui [1 ]
机构：
[1] Princess Margaret Canc Ctr, Radiat Oncol, Toronto, ON, Canada
来源：
RADIOTHERAPY AND ONCOLOGY | 2024年 / 192卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
270
引用
收藏
页码：S9 / S10
页数：3
相关论文
共 50 条
  • [21] Risk of Pathologic Extranodal Extension and Other Adverse Features After Transoral Robotic Surgery in Patients With HPV-Positive Oropharynx Cancer
    Zebolsky, Aaron L.
    George, Elizabeth
    Gulati, Arushi
    Wai, Katherine C.
    Carpenter, Patrick
    Van Zante, Annemieke
    Ha, Patrick K.
    Heaton, Chase M.
    Ryan, William R.
    JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2021, 147 (12) : 1080 - 1088
  • [22] Prognostic value of inflammatory markers in HPV-positive and HPV-negative patients with oropharyngeal cancer (OPC)
    Mrochem-Kwarciak, Jolanta
    Rutkowski, Tomasz
    Wygoda, Andrzej
    Chmura, Aleksandra
    Deja, Regina
    Skladowski, Krzysztof
    ORAL ONCOLOGY, 2021, 118
  • [23] Prognostic value of inflammatory markers in HPV-positive and HPV-negative patients with oropharyngeal cancer (OPC)
    Mrochem-Kwarciak, Jolanta
    Wygoda, Andrzej
    Rutkowski, Tomasz
    Chmura, Aleksandra
    Deja, Regina
    Mazurek, Agnieszka
    Skladowski, Krzysztof
    ORAL ONCOLOGY, 2021, 118
  • [24] Trends in Adjuvant Chemoradiation Usage for Patients with HPV plus Oropharyngeal Cancer and Pathologic Extranodal Extension
    Husain, Z. A.
    An, Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E809 - E809
  • [25] Stage I HPV-positive oropharyngeal cancer: Should all patients receive similar treatments?
    Yoshida, Emi J.
    Luu, Michael
    Mallen-St Clair, Jon
    Mita, Alain C.
    Scher, Kevin S.
    Lu, Diana J.
    Nguyen, Anthony T.
    Shiao, Stephen L.
    Ho, Allen S.
    Zumsteg, Zachary S.
    CANCER, 2020, 126 (01) : 58 - 66
  • [26] Stage I HPV-positive Oropharyngeal Cancer: Should All Patients Receive Similar Treatments?
    Yoshida, E. J.
    Luu, M.
    Mallen-St Clair, J.
    Mita, A.
    Scher, K.
    Lu, D. J.
    Nguyen, A. T.
    Ho, A. S.
    Zumsteg, Z. S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E431 - E432
  • [27] The Impact of Hospital Safety-Net Burden Status on Patients with HPV-Positive Oropharyngeal Cancer
    Gilja, Shivee
    Kumar, Arvind
    Kapustin, Danielle
    Su, Vivian
    Rubin, Samuel J.
    Chai, Raymond
    Roof, Scott A.
    Khan, Mohemmed N.
    LARYNGOSCOPE, 2024, 134 (04): : 1733 - 1740
  • [28] Cetuximab versus cisplatin in patients with HPV-positive, low risk oropharyngeal cancer, receiving radical radiotherapy
    Mehanna, H.
    Kong, A.
    Hartley, A.
    Mistry, P.
    Dalby, M.
    Fulton-Lieuw, T.
    Robinson, M.
    Gray, A.
    Foran, B.
    Sen, M.
    O'Toole, L.
    Dyker, K.
    Al Booz, H.
    Moleron, R.
    Brennan, S.
    Aynsley, E.
    Chan, A.
    Srinivasan, D.
    Buter, J.
    Dunn, J.
    ANNALS OF ONCOLOGY, 2018, 29 : 729 - 730
  • [29] Lymphocyte telomere length predicts clinical outcomes of HPV-positive oropharyngeal cancer patients after definitive radiotherapy
    Luo, Xiaoning
    Sturgis, Erich M.
    Yang, Zheng
    Sun, Yan
    Wei, Peng
    Liu, Zhensheng
    Wei, Qingyi
    Li, Guojun
    CARCINOGENESIS, 2019, 40 (06) : 735 - 741
  • [30] HPV-Positive Oropharyngeal Cancer Increased for Both Black and White Patients Over Time, 1992-2007
    Zandberg, D. P.
    Liu, S. Z.
    Goloubeva, O.
    Schumaker, L. M.
    Cullen, K. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 88 (02): : 494 - 495
12345